MFN Comes Roaring Back as Trump Sends Letters Pushing 17 Companies to Offer MFN Prices

It’s a quiet summer Friday, and I’m going to take advantage of the slow news flow to spend a little extra time on one of my favorite activities: handicapping future

Last month, Mel Whittington, who runs the Leerink Center for Pharmacoeconomics, had me on her podcast to discuss the intersection between communications and health economics. I had a blast, and

Thanks to everyone who weighed in on the future of Cost Curve yesterday. I’m keeping the survey open for another day, so if you haven’t clicked over, I’d be appreciative